Opus Genetics, Inc. Short-term Debt
Opus Genetics, Inc. (IRD) had Short-term Debt of $0 as of 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:ShortTermBorrowings · last filed 2024-03-08
- 2022-12-31: Short-term Debt $0.00.
- 2022-09-30: Short-term Debt $0.00.
- 2022-06-30: Short-term Debt $0.00.
- 2022-03-31: Short-term Debt $215.00K.
| Period end | Short-term Debt |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-30 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-04 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-12 |
| 2022-03-31 | $215.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $538.00K 10-K · filed 2023-03-30 |
| 2021-11-30 | $600.00K 10-K · filed 2024-03-08 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |